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Measuringthe Public Health Impactofthe
Aneuploidies
by Howard B. Newcombe*
fitheprotectionofmanagainst mutagenicagentsingeneral, andagainstthosethatcauseaneuploidies in
particular, is to have an increasingly rational basis with the passage of time, quantitative or at least
semniquantitativeassessmentsofrisksareneeded. Theseshouldtakeintoaccountboththelikey numbersof
Induced cases and the likely severities ofthe differentconditions. In the past, quantitative datarelating to
severity have been Umited or nonexistent, but the data sources exist by which foliow-up studies may be
carried out to determine age-specific and cumulative risks ofhospitalization and death, the durations of
hopital stays, and the economic burden to society which these represent. To ilustrate the use of such
sources, the cumulative risks of death in children with anomalies of the autosomes and of the sex
chromosomes, over the first 19 years oflife, are compared with those for other kinds ofhereditary and
environmentally caused handicaps that are reported in that age group.
Introduction
Although most ofthe discussion in this workshop
will have todowiththe occurrence ofaneuploidies in
lowerorganisms; the ultimate objective ofour delib-
erations would appear to be the protection of man
against possible increases in the frequency of
chromosomal diseases arising from the presence of
mutagens in the environment. I note in this connec-
tion that the first session and the last formal presen-
tation deal respectively with the "human aspects"
and the "moral implications" of aneuploidy, and
that the sponsoring organization has as its prime
mission the protection ofman against environmental
cause of ill health.
It would appear appropriate, therefore, to con-
sider for a moment the kinds ofinformation that are
mostneeded iftheprotection ofman against harmful
environmental agents, and more specifically against
the various kinds of environmental mutagens, is to
have an increasingly rational and quantitative basis
with the passage of time.
If it were possible simply to ban the use of all
agents known to have mutagenic effects, the task of
the scientist could be largely limited to that of de-
signing screeningprocedures thatwould identify any
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substances that had, or were likely to have,
mutagenic activity in man. Experience with radia-
tion protection, however, has taught us that the
problemisessentiallyquantitativeinnature, andthat
thegoal ofabsolute safety, ifpursued withoutregard
to competing risks, can bring hardships of other
kinds, for example, debate over the merits ofmam-
mography centers, not on a question ofbanning the
procedure, but ratheron ascertaining what ages and
other circumstances render the benefits likely to
outweightherisks. The samewouldbetrueforuseof
amutagenic and presumably carcinogenic drug such
as metronidazole (Flagyl) for amebic dysentry and
vaginal trichomoniasis when alternative forms of
therapy are less effective or more toxic or both.
It is therefore not sufficient that environmental
mutagens be identified, unless something is known
about their potencies, to provide at least a clue con-
cerning the amount of human trouble that might re-
sult from exposure to them.
In the case of radiation, the chairmen of various
committees and subcommittees concerned with
protection have, with considerable difficulty, per-
suaded geneticists to come up with what they think
are the most likely numbers of affected individuals
resulting from the exposure of a given number of
people to particular levels of radiation. But even
such numbers are poor indicators of harm if one
lacks a satisfactory measure of the spectrum of
3severities among the various individuals affected
by the hereditary conditions. For both the chromo-
somal and the nonchromosomal genetic disease of
man there is a curious lack ofquantitative data per-
taining to severity. Thus, reports which attempt to
compare, forexample, the magnitude ofthe somatic
harm with that ofthe genetic harm, and to derive an
indicatorofthetotal detrimentofthetwokindstaken
together are pretty much forced to give equal weight
to a cancer death and to a genetic disease, in the
belief that the geneticists have included only the
cases with serious manifestations.
For cancer deaths, of course, the magnitudes of
the harm to individuals will vary in measurable ways
with respect, forexample, to the extent ofthe loss of
life expectancy, the amount of use made of health
care facilities, and the economic burden to society.
The spectrum for each such variable is quantifiable,
and there is considerable interest in the acquisition
and use ofrelevant raw data pertaining to cancer. In
principle, the same sorts of indicators of severity
could be applied also to the hereditary diseases, in
particulartothechromosomal anomalies, buthuman
geneticists tendtobe much less preoccupiedwiththe
quantitative public health aspects oftheir speciality
than are the cancer epidemiologists.
This brings me to the main thrust of the present
paper. When estimating radiation risks we have
tended toequate inducedcancerdeaths withinduced
genetic defects, and to add the two together as a
measure of the total harm. What is lacking is some
knowledge of the numbers of individuals who are
only mildly affected by the hereditary conditions,
and the numbers for whom the disease is equal to or
worse thandyingofcancerand losing on the average
some 10-12 years of life expectancy.
At least a few statistical measures of severity are
now possible, however, for the hereditary traits in-
cluding the aneuploidies, and I propose to discuss
briefly the methods by which these measures may be
applied and to give examples.
Data Sources
The data sources to which I will refer relate to
the population of the Canadian province of British
Columbia which now numbers somewhat over
2,000,000 people. The province has an exceptionally
well organized registry of handicapping conditions,
plus a surveillance scheme forcongenital anomalies,
so that exceedingly few cases of serious hereditary
conditions appearing in the first decade ortwo oflife
escape inclusion in the recording system.
The unique feature of the data base, however,
does not liejust inthe contents ofthese files, but has
to do rather with the special manner in which they
are organized forfollow up. Each ill-health record is
linked by computersearch withthe appropriate birth
registration (ifthat event occurred in British Colum-
bia during 1946 or later) and with the appropriate
death registration (ifthe individual died in the prov-
ince). Added into these follow-up histories are the
records ofhospitalizations ofchildren overa 10-year
period, based on the files of a universal system of
hospital insurance. The death registrations and hos-
pital records serve also as a check on the complete-
nessofregistration ofsome ofthe handicapping con-
ditions of interest (1-5). Needed for such follow-up
are the full birth names and birth dates, plus prov-
inces, statesorcountries ofbirth,andwherepossible
the mother's maiden surname as identifying sibling
group and aidingfurtherthe resolution ofambiguous
matches.
This work, which was carried out at Chalk River,
mainlyby MissMartha Smith, has nowbeenentirely
transferred totheDepartmentofMedical Genetics at
the University ofBritish Columbia, underDr. James
R. Miller who is assisted by Mr. Soo Hong Uh. The
late Dr. Benjamin K. Trimble was in directcharge of
the work there until the time of his death last year.
The total machine-readable files, including the vital
registrations back to 1946, numbered well over a
million records ofhealth related events, all contain-
ing personal identifying information to permit the
compilation of individual lifetime histories.
The computerlinkages are exceedingly rapid, and
it has beenpossible to carry out searches ofthe large
birth files and to obtain linkages with incoming
handicap, surveillance, hospital, and death records
atarateofsome40,000perminute(6). Inthis manner
lifetime health histories have been constructed for
handicapped children, and for control groups con-
sisting of all children born in the same years. From
these histories it is possible to derive such measures
ofseverity as the age-specific death rates, hospitali-
zation rates, and durations of stay in hospital. Per-
mission to use the vital records in this study was
obtained through Statistics Canada, from the Health
Branch, Department of Health and Welfare, Prov-
ince ofBritish Columbia. The permission was condi-
tional upon strict observance ofthe oath of secrecy
respecting the nonstatistical information contained
in the records.
To such measures ofseverity may be added regis-
tration itself, as representing some sortofthreshold.
It is appropriate to consider this first.
Registration as a Measure of
Severity
Even good registries of handicapping conditions
are commonly regarded as failing to ascertain many
Environmental Health Perspectives 4Table 1. Frequencies of chromosome anomalies.
Chromosome anomalies/
100 liveborn
Special Handicap
surveysa registrationsb
Down's syndrome 0.12 0.16-0.19
Other autosomal trisomies 0.02 0.01
Sex chromosome anomalies 0.22
Autosomal structural anomalies 0.24
Total 0.60 0.16-0.20
ajjN data (9).
bData ofTrimble and Doughty (7).
cases ofthe important hereditary diseases, but such
under-registration tends to be highly selective, and
the extent of it is relevant and informative. For ex-
ample, whereas Down's syndrome and the other
autosomal trisomies clearly represent major handi-
caps for the affected individuals and severe burdens
on the families and society, the same cannot be said
ofthe majority ofthe sex chromosome anomalies, or
of most translocations and other rearrangements.
The British Columbia registry does in fact, fail to
include about two-thirds of the total cases of
chromosome anomalies as estimated in a recent
United Nations report (7-9). The exclusions, how-
ever, are of the less severe traits; included in the
registry are, if anything, more cases of automosal
trisomies than would be expected from the data in
the UN report (Table 1).
Clearly, ifonewereattempting toassessthepublic
health impact of the chromosome anomalies, it
would be quite misleading to use the survey totals
quoted in the UN document, without weighting for
severity. The registration process in British Colum-
bia has already created a distinction on the basis of
severity. The extent of the affliction in the case of
Down's syndrome, which is well registered, is prob-
ablymuchgreaterthanthatassociatedwitha 10-year
lossoflifeexpectancy due to acancerdeath, but one
would hesitate to say the same concerning the extent
ofthe afflication with Turner's or Kleinfelter's syn-
drome which are incompletely registered.
The total number ofcases ofall types ofchromo-
some anomaly has therefore limited meaning as a
measure ofpublic health impact, butit does get used
inthe process ofassessingradiation risks, alongwith
the numbers ofother genetic disorders, and often in
proximity with the numbers of cancer deaths.
Death Rates as Indicating
Severity
Thereis, ofcourse, nosingle quantifiable indicator
of severity that can be applied with equal appropri-
ateness to all diseases including those caused by the
aneuploidies. One is forced to consider first those
indicators that are most readily available. In the case
of the British Columbia files, each of the personal
health related records has been linked into an indi-
vidual chronological history in a fashion that would
permit one to extract the sequence of successive
hospitalizations of an individual, so that from these
one could derive both the age specific and the
cumulative frequencies of admissions and dis-
charges, and the durations of stay. However it
seemed simpler and more appropriate to start first
with age-specific and cumulative frequencies of
death, not that this provided as good a measure of
severity, but simply because the other kinds ofdata
would be more difficult to interpret if one had not
already analyzed the information pertaining to
death. Furthermore, the methods for analysis ofthe
dataon hospitalization would be easier to develop if
similar methods had been worked out first for the
mortality data.
There is another reason for emphasizing death
frequencies in study populations as a useful even if
imperfect measure of severity. This is that the mor-
talitydatawillbecome much more readily accessible
in the future, both in Canada and in the U.S.A.
Canada now has a computerized "mortality data
base" with which it is possible to search rapidly for
death records on a very large scale indeed, and the
United States is in the early stages ofdeveloping the
plans for a national death index, intended to serve a
similar purpose. Undoubtedly both facilities will be
used increasingly by epidemiologists, for the pur-
pose ofassessing the public health impacts ofharm-
ful agents in the workplace, and perhaps also in the
environment away from work. So there is no reason
why human geneticists could not, in the same fash-
ion, follow up any large group ofindividuals known
to have hereditary-more specifically, chromosom-
ally caused-disabilities.
Human geneticists do provide, from time to time,
anecdotal evidence that this or that disease is really
quite severe, but almost never are the statistics ade-
quate to describe the range of severity for any par-
ticularcondition, letalone forthe whole ofanybroad
category of genetic disease such as that due to
aneuploidies. As a result, one begins to wonder
whether subjective impressions in these matters are
to be trusted, and why there is so little interest in
collecting appropriate quantitative data on an ade-
quate scale.
With this in mind I will first show agraph illustrat-
ing the kind ofresults obtained from the British Co-
lumbia files by Tony Chu, a computer science stu-
dentwho worked with us duringthe summerof1977,
August 1979 5and will then go on to describe some of
ties in defining precisely what it is on
measure.
Some Results
Perhaps the simplest comparison ma(
by the linked personal histories has to c
cumulativenumbers ofdeaths incohorts 4
In Figure 1 the deaths in handicapped c
expressed as a factor by which these
expected numbers ofdeaths as based on
the same years. The figure compares
cases of sex chromosomes (S.C.) and
chromosome (A.C.) diseases with the
broad etiological categories represen
handicap registry, i.e., with the recessi
dominant (DOM), congenital malformati
sex-linked (S.L.), multifactorial excludii
genital malformations (MULT), enviri
caused (ENV), and unknown (UNKN)
The graphs are based on some 26,189 af]
dreninall, ofwhom928 havechromosom
Cumulative mortality is shown in this m;
the end of each year of life over the firs
To judge from these comparisons, ti
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These different degrees of severity apply, how-
ever, only to the cases that actually got into the
registry, and areclearly not applicable to those man-
ifestations that were too mild to be registered. For
example, thecurveforthe sex chromosomediseases
is based on only 43 cases, as against 885 for the
autosomal chromosomal anomalies which are
mainly Down's syndrome. Whereas virtually all of
the latter category would be severe enough as to be
registered as handicapping, only afraction ofthe sex
chromosome anomalies are registered, and these
were presumably not a random sample but were
probably selectedforamuch higherdegree ofsever-
ity than is usual in that category.
In assessing the public health impact of the
chromosomal diseases one should clearly not take
dataondegrees ofseverity as derivedfromthe cases
that have attracted special attention, and then infer
thatthese severities aretypicalofthetotalnumberof
cases as derived from surveys that have aimed at
complete ascertainment.
Some Complications
it 19 years. Ideally, severityoughttobemeasured onthebasis
ie chromo- of such follow-up histories, but with the follow-up
less severe extended over the whole of the life span. If one
ial in sever- thinks, for example, in terms of comparisons with
ital malfor- cancer, itisthe severities ofallofthecasesoccurring
the remain- over the whole of the life span that are of major
interest. Of all cancer cases it can be said that
roughly one-halfare curable and that the remaining
affected individuals lose on the average some 10-12
years oflife expectancy. It is in such terms that one
would like to express the severities of hereditary
diseases when using mortality as the indicator. Un-
less the two sorts ofconditions are treated in a simi-
lar fashion, it will always be difficult to compare in
any rational way the relative importance of the ge-
netic risk with the somatic risk from exposure to
agents which cause both kinds ofeffect.
Among the hereditary diseases, those with reces-
sive etiology tend to have their full impact early in
life, whereas a majority of severe dominant traits
(like multiple polyposis of the colon and Hunting-
ton's chorea) have late onsets. Ofthe chromosomal
diseases, Down's syndrome tends to be severe and
e to have its full impact early in life, whereas the sex
chromosomal anomalies tend to be mild and to es-
capenoticeuntilafterpuberty. Thus, again, fromthe
standpointofpublichealthimportance, whateverthe
5 ' 19 measure ofseveritychosen, itrequires to beapplied
over the whole ofthe lifespan.
longcases of For the chromosomal diseases, mortality may be
sesandother one ofthe least useful ofthe indicators of severity,
and this would be particularly true of Down's syn-
Environmental Health Perspectives 6drome which results in prolonged stays in institu-
tions from an early age. In such circumstances, the
burden on society is perhaps inversely related to
mortality. Nevertheless, data on mortality are more
readily obtainable by follow up, using the death reg-
istrations, than are data on institutionalization using
hospital records that are not centralized in any read-
ily accessible form. For this reason, mortality data
should be used where possible, and this use ought to
serve as a model for subsequent efforts to measure
severity statistically in terms of the social burden
arising out ofthe use of institutional facilities.
Practical Problems
For those who might think that the existence ofa
computerized data base of personal records, linked
into individual histories, makes it possible to extract
relevant data at the press ofa button, I should men-
tion a few of the practical problems. These are as-
sociated chiefly with incompleteness of the files.
In the case ofthe British Columbiafiles, birth and
death records were available back to 1946 in
machine-readable form. However, the handicap
registrations were not equally complete for all birth
years, and alsotheages atwhichaffected individuals
were registered varied widely. In general, (a) the
most recentbirth cohorts had not had sufficient time
topermitahighproportion ofregisterable conditions
to be detected and reported, (b) the earliest birth
cohorts were born at a time when handicap registra-
tion was much less complete than it is now, and (c)
the intermediate birth cohorts fallfar shortofhaving
life time histories as long as one would wish for the
purpose of quantifying severity (6). Despite all of
this, an attempt had to be made to derive as much
guidance as possible from the files, and so even the
shorter periods offollow up were used to the full.
Delayed ascertainment of the condition created
specialproblems. Oughtone,forexample, toassume
that the expression ofa disease had not been severe
prior to registration of a case, and that the risk of
death was normal in that earlier period? Or, should
oneassumethatthedegreeofseverityobservedafter
registrationwastypical ofthatoverthe priorperiod?
Foracancer, the former assumption might be closer
to the truth, but for a chromosomal disease this is
less certain. In carrying out the arithmetic, one or
otherofthe two arguments must be made, or, better
still, both may be made so as to arrive at a maximum
and minimum estimate of lifetime severity.
Is the Public Health Approach
Necessary?
Forthose who are primarily involved in the use of
lower organisms to screen for various kinds of
mutagenic activity the present concern with
measuringthepublic health impactwill seem remote
and premature. But, as soon as an attemptismade to
protect man against a particular mutagen, the unan-
swered, and often unanswerable, question concern-
ing the importance orlack ofimportance ofthe pub-
lic health impact gets raised almost immediately.
Rarely can one avoid it by simply advising that a
mutagen be banned orthat exposure to it be kept as
low as possible. What tends to be forgotten in this
approach is that some mutagenic agents are ex-
ceedingly useful to society and difficult to replace,
while others are not readily avoidable without sub-
stantial expenditures ofsociety's limited resources.
Public health officials are continually bombarded
with proposals for improving the environment in
which we live and they must necessarily strive to
rank these in some sort ofpriority. At the very least
even an exceedingly crude and tentative indication
of the magnitude of the public health impact of a
harnful substance is needed, ifwe are to achieve a
reduction in the exposure to it with the assurance
that the harm or cost associated with this reduction
has not resulted in greater human hardship than that
which one sought to avoid. Only for a virtually use-
less substance, that costs little to get rid ofand that
nobody wants very much, is the ideaofa simple ban
likelyto beimmediately acceptable inthe absenceof
some sort ofassessment ofthe harm it may be caus-
ing to the health of the public.
Forthe last20years ormore geneticists have been
tryingtoassessthepublic health impactofradiation,
in terms ofthe numbers ofcases ofinduced heredi-
tary disease, butwith little or no emphasis on statis-
tical indicators ofcollective severity. The latest UN
report lists surveys that include some 55,679 new-
born infants of whom 336 were found to have
chromosomal abnormalities; no mention was made
in the report, of plans to follow any of these 336
infants to determine how severely affected the indi-
viduals will be throughout their subsequent lives.
Perhaps a quarter of the number will be in-
stitutionalized until they die. But, for the rest, the
public health impact is essentially unquantified.
Fortunately, the methods for individual follow-up
nowexistbywhich one can begin to rectifythis kind
ofomission and the resulting epidemiological gap in
our understanding of man's genetic well-being.
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